Diabetes and COVID-19: Role of insulin resistance as a risk factor for COVID-19 severity.

导出 LinkOut

翻译打印收藏纠错

作者： Charitha,Gangadharan ^[1] ; Rupa,Ahluwalia ^[2] ; Alben,Sigamani ^[3]

作者单位： Department of Clinical Research, Narayana Hrudayalaya Limited, Bangalore 560099, Karnataka, India. ^[1] Consultant in Diabetes and Endocrinology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich NR4 7UY, United Kingdom. ^[2] Chief Scientific Officer, Numen Health, Bangalore 560095, Karnataka, India. dralbens@numenhealth.com. ^[3]

关键词 Blood flow measurements Inflammation Insulin resistance Renin–angiotensin system Severity of COVID-19 Thrombosis

DOI 10.4239/wjd.v12.i9.1550

PMID 34630907

发布时间 2021-10-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

World journal of diabetes

2021年12卷9期

1550-1562页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Diabetes and COVID-19: Role of insulin resistance as a risk factor for COVID-19 severity.

World journal of diabetes

相似文献

World journal of diabetes

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Diabetes and COVID-19: Role of insulin resistance as a risk factor for COVID-19 severity.

World journal of diabetes

相似文献

World journal of diabetes

相关期刊

检索历史清除